Travel Vaccines Market to Grow at 6.83% CAGR to 2020
PUNE, India, December 2, 2016 /PRNewswire/ --
The global travel vaccines market analyst says R&D is budding due to a strong need for new efficacious and better tolerated vaccines. The market presents huge growth potential for vendors because of the growing incidence of infectious disease. This requirement is creating a demand for novel vaccines where major players are focusing their R&D efforts and once launched, should become the major growth drivers. Increased investment in R&D by major pharmaceutical companies would fuel the growth of the global travel vaccines market.
Complete report on travel vaccines market spread across 60 pages, analysing 4 major companies and providing 64 data exhibits now available at http://www.reportsnreports.com/reports/769803-global-travel-vaccines-market-2016-2020.html.
This analyst forecast the global travel vaccines market to grow at a CAGR of 6.83% during the period 2016-2020. According to the travel vaccines market report, the growing demand for vaccines among international travellers is one of the major factors driving the market growth. Many international and national bodies have mandated that the immigrants should be vaccinated before traveling to disease-prone areas. Considering vaccines are largely perceived as a prevention mechanism against the spread of any infectious disease; it is making a specific requirement in international traveller's list.
The Americas was the highest revenue contributing region in the travel vaccines market during 2015 and will continue to lead the market in the coming years. The US was one of the highest revenue contributors in the region, capturing a significant portion of the global market. The increasing demand for vaccines that cater to the unmet medical needs provides an opportunity for vendors to develop new safe and efficient molecules, which will aid in the growth of travel vaccines market in the region.
The combination vaccines segment is one of the fastest growing segments of the travel vaccines market. These vaccines confer protection against different causative agents for diseases such as meningitis, measles, rubella, mumps, diphtheria, pertussis, and tetanus.
The following companies are the key players in the global travel vaccines market: GlaxoSmithKline, Merck, Pfizer, and Sanofi. Other prominent vendors in the market are: Abbott, AstraZeneca, Bavarian Nordic, Baxter, Beijing Minhai Biotechnology, Bharat Biotech, Bharat Immunologicals and Biologicals, Bio-Med, Seqirus CSL, Crucell, CSL, Dynavax Technologies, Emergent BioSolutions, GlycoVaxyn, GreenSignal Bio Pharma, Hualan Biological Engineering, Imunoloski Zavod, Indian Immunologicals, Janssen Pharmaceuticals, JN International Medical, Kaketsuken, LG Life Sciences, Lupin, Mitsubishi Tanabe Pharma, Novavax, Nuron Biotech, Panacea Biotec, Pfizer, Protein Sciences, Roche, SK Chemicals, Serum Institute of India, Shenzhen Kangtai Biological Products, Sinovac Biotech, Takeda Pharmaceutical, Vacunas Finlay, Valeant Pharmaceuticals, Valneva, and Zydus Cadila. Order a copy of Global Travel Vaccines Market 2016-2020 report @ http://www.reportsnreports.com/purchase.aspx?name=769803.
Global Travel Vaccines Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. This report covers the present scenario and the growth prospects of the global travel vaccines market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of various vaccines administered to actively immunize meningococcal disease, Japanese encephalitis, rabies, typhoid, yellow fever, hepatitis B, and hepatitis A. The report also considers the revenues to be generated from the sales of vaccines that are expected to be launched into the market during the forecast period.
Another related report is Global Human Vaccine Market 2016-2020, a major trend being witnessed in the global human vaccines market is the increase in strategic alliances. Increase in threat from regional vendors in developing countries may cause price erosion and may compel major players to operate under low-margin models. M&A are usually intended to increase the market penetration of the acquirer or to enhance the product portfolio of the parent company. Browse complete report @ http://www.reportsnreports.com/reports/461270-global-human-vaccine-market-2016-2020.html.
Explore other new reports on Pharmaceuticals Market @ http://www.reportsnreports.com/market-research/pharmaceuticals/.
About Us:
ReportsnReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 100+ leading global publishers & in-depth market research studies of over 5000 micro markets. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports.
Contact:
Ritesh Tiwari
2nd Floor, Metropole,
Next to Inox Theatre,
Bund Garden Road,
Pune - 411001
Maharashtra, India.
Tel: +1-888-391-5441
[email protected]
Connect With Us on:
Facebook: https://www.facebook.com/pages/ReportsnReports/191441427571689
LinkedIn: http://www.linkedin.com/company/reportsnreports
Twitter: https: //twitter.com/marketsreports
G+ / Google Plus: https://plus.google.com/111656568937629536321/posts
Pinterest: http://www.pinterest.com/comeonseo/reportsnreports/
RSS/Feeds: http: //http://www.reportsnreports.com/feed/l-latestreports.xml
Share this article